# Medical Cannabis Can Provide Sustained Relief for Migraines – NORML > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/longitudinal-study-medical-cannabis-migraine-relief/ > **Published:** 2026-04-09T16:29:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:26:22-04:00 > **Clinical Summary:** This longitudinal study medical cannabis migraine research shows sustained relief and preventive benefits for migraine sufferers over extended treatment periods. --- ✦ New CED Clinical Relevance  #76Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic MigrainePain ManagementPreventive TherapyChronic ConditionsLongitudinal Data Why This Matters Migraine affects 12% of the population with limited effective treatments, and this longitudinal data provides evidence for sustained therapeutic benefit rather than just acute relief. The study’s real-world design offers clinically relevant insights into cannabis as a preventive migraine therapy. Clinical Summary A longitudinal study tracked migraine patients using [medical cannabis products](https://cedclinic.com/cannabis-infused-products-skin-diy-topical-recipes/) and found sustained improvements in migraine frequency and severity over extended treatment periods. The research suggests cannabis may offer both acute relief and preventive benefits for migraine sufferers, though specific dosing protocols and product formulations varied among participants. The study design reflected real-world [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use rather than controlled clinical trial conditions. Dr. Caplan’s Take “This adds to our understanding that cannabis may work preventively for migraines, not just as rescue therapy. I’m encouraged by the sustained benefit signal, but we still need standardized protocols to guide dosing and product selection for optimal outcomes.” Clinical Perspective 🧠 Patients with treatment-resistant migraines may benefit from discussing cannabis as both acute and preventive therapy with their clinicians. Consider starting with low-dose, consistent daily dosing rather than only using cannabis during acute episodes. Monitor both frequency reduction and functional improvement over 3-6 month periods. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medical%20Cannabis%20Can%20Provide%20Sustained%20Relief%20for%20Migraines%20-%20NORML%20%40drcaplan&url=https%3A//norml.org/news/2026/04/09/longitudinal-study-medical-cannabis-products-provide-sustained-improvements-for-migraine-patients/%3Famp)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//norml.org/news/2026/04/09/longitudinal-study-medical-cannabis-products-provide-sustained-improvements-for-migraine-patients/%3Famp)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medical%20Cannabis%20Can%20Provide%20Sustained%20Relief%20for%20Migraines%20-%20NORML%20--%20via%20%40drcaplan.bsky.social%20https%3A//norml.org/news/2026/04/09/longitudinal-study-medical-cannabis-products-provide-sustained-improvements-for-migraine-patients/%3Famp)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://norml.org/news/2026/04/09/longitudinal-study-medical-cannabis-products-provide-sustained-improvements-for-migraine-patients/?amp](https://norml.org/news/2026/04/09/longitudinal-study-medical-cannabis-products-provide-sustained-improvements-for-migraine-patients/?amp) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating for this cannabis research?](#What_is_the_clinical_relevance_rating_for_this_cannabis_research) - [What medical conditions does this cannabis research focus on?](#What_medical_conditions_does_this_cannabis_research_focus_on) - [Is this considered new research in the cannabis field?](#Is_this_considered_new_research_in_the_cannabis_field) - [What type of therapy approach does this research examine?](#What_type_of_therapy_approach_does_this_research_examine) - [Why should clinicians pay attention to this cannabis research?](#Why_should_clinicians_pay_attention_to_this_cannabis_research) - [Related](#Related) ## FAQ #### What is the clinical relevance rating for this cannabis research? This study has been assigned CED Clinical Relevance #76 with “Notable Clinical Interest” status. This indicates emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What medical conditions does this cannabis research focus on? The research primarily focuses on migraine treatment and pain management. It also examines preventive therapy approaches for chronic conditions. #### Is this considered new research in the cannabis field? Yes, this is marked as new research in [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). The findings represent recent developments in understanding cannabis applications for neurological conditions. #### What type of therapy approach does this research examine? The research specifically looks at preventive therapy using [cannabis for chronic conditions](https://cedclinic.com/rhode-island-medical-marijuana-card-qualifying-conditions/). This suggests a focus on long-term management rather than just acute symptom relief. #### Why should clinicians pay attention to this cannabis research? This research has been flagged for its notable clinical interest, indicating potential implications for patient care. The focus on migraine prevention and [chronic pain management](https://cedclinic.com/cannabinoids-in-reward-processing-pain-perception/) addresses common clinical challenges that many practitioners encounter. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Migraine – PubMed](https://cedclinic.com/uk-medical-cannabis-registry-migraine-outcomes-analysis/) Explore clinical outcomes from the UK registry analyzing [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use for migraine treatment and management. [Read More](https://cedclinic.com/uk-medical-cannabis-registry-migraine-outcomes-analysis/) [Are medical cannabis patients finally finding lasting relief from migraines? New research shows …](https://cedclinic.com/cannabis-efficacy-migraine-management-new-research/) New research investigates whether medical cannabis provides lasting relief for migraine patients beyond acute episodes. [Discover Insights](https://cedclinic.com/cannabis-efficacy-migraine-management-new-research/) [Medical Cannabis Linked to Meaningful Pain-Related Improvements in Large Minnesota Study](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) A large study from Minnesota links medical cannabis use to significant improvements in pain management, relevant for migraine sufferers. [Learn More](https://cedclinic.com/medical-cannabis-linked-to-meaningful-pain-related-improvements-in-large-minnesota-study/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).